Sign inJoin waitlistJoin the waitlist

Erez Baruch

Assistant Professor, Melanoma Medical Oncology · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present

Hematology and Medical Oncology
University of Texas Health Science Center at Houston
2023–2026
University of Texas M D Anderson Cancer Center
2022–2025
Internal Medicine
University of Texas Health Science Center at Houston
2020–2022
Tel Aviv University
2020
McGovern Medical School
2007–2011
Tel Aviv Sourasky Medical Center
2010–2011

Research

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Science · 2021 · First of 32 authors · Corresponding · 1,371 citations
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Science · 2021 · 792 citations
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Nature Medicine · 2021 · 380 citations

Jennifer Wargo
9 papers
Moran Amit
5 papers · 3 as a resident
James Allison
4 papers
Jeffrey Myers
4 papers
Michael Davies
4 papers
Michael Migden
4 papers
Neil Gross
4 papers
Padmanee Sharma
4 papers
Renata Ferrarotto
4 papers
Ryan Goepfert
4 papers
Kenneth Tsai
3 papers
Michael White
3 papers · 2 as a fellow

Grants

Adverse Gut Microbiome Promotes Resistance Immune Checkpoint Inhibitors via Chronic Inflammation
National Cancer Institute · R00
Contact PI · $248.7K · University of Tx Md Anderson Can Ctr
2025–2028
Adverse Gut Microbiome Promotes Resistance Immune Checkpoint Inhibitors via Chronic Inflammation
National Cancer Institute · K99
Contact PI · $32.4K · University of Tx Md Anderson Can Ctr
2025–2026

Clinical trials

Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2024–2030
Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2024–2029
Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2024–2029
Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2020–2026